Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 3Osteoporosis 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Pain 1Neoplasm Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Analgesia 6Zoledronic Acid 5Prednisone 4Docetaxel 4Radiotherapy 3cabozantinib 2Psychiatric Rehabilitation 2Mitoxantrone 2Lidocaine 2Filgrastim 2Cystoscopy 2tandutinib 1strontium chloride 1pegfilgrastim 1Vitamin D 1Vertebroplasty 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Strontium-89 1Samarium-153 1Radium-223 1Radiation 1Oxygen 1Observation 1Nitrous Oxide 1Morphine 1Midazolam 1Methadone 1Mepivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Calcium × Genitourinary × Clear all
NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
261 enrolled 12 charts
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡